OBJECTIVE: To elucidate the role of tumor necrosis factor α-induced adipose-related protein (TIARP; or tumor necrosis factor α-induced protein 9 [TNFAIP-9]) in the development and pathogenesis of arthritis. METHODS: We generated TIARP-deficient (TIARP(-/-) ) mice and investigated several organs in aged mice. Peritoneal macrophages were collected and cultured with lipopolysaccharide (LPS) and TNFα, and then the production of cytokines and subsequent NF-κB signal transduction were analyzed. We also examined the susceptibility of young TIARP(-/-) mice to collagen-induced arthritis (CIA). Draining lymph nodes and splenocytes were isolated and cultured, and serum levels of anti-type II collagen (anti-CII) antibodies, interleukin-6 (IL-6), and TNFα on day 60 were measured. We further investigated the effects of anti-IL-6 receptor monoclonal antibody (mAb) on the development of arthritis in TIARP(-/-) mice. IL-6/STAT-3 signaling was also analyzed using TIARP(-/-) macrophages. RESULTS: TIARP(-/-) mice developed spontaneous enthesitis and synovitis, had high serum levels of IL-6, had increased CD11b+ cell counts in the spleen, and showed enhanced LPS- and TNFα-induced IL-6 expression in macrophages. Sustained degradation of IκBα with dysregulated apoptosis was also noted in TIARP(-/-) macrophages. CIA was clearly exacerbated in TIARP(-/-) mice, accompanied by marked neutrophil and macrophage infiltration in joints. The levels of anti-CII antibodies in serum were unchanged, whereas autoreactive Th1 cell and Th17 cell responses were higher in TIARP(-/-) mice. Treatment with anti-IL-6 receptor mAb prevented the development of CIA in TIARP(-/-) mice, and TIARP(-/-) macrophages showed increased IL-6-induced STAT-3 phosphorylation. CONCLUSION: These findings suggest that TIARP acts as a negative regulator of arthritis by suppressing IL-6 production, its signaling and TNFα-induced NF-κB signaling, resulting in enhanced apoptosis in macrophages.
OBJECTIVE: To elucidate the role of tumor necrosis factor α-induced adipose-related protein (TIARP; or tumor necrosis factor α-induced protein 9 [TNFAIP-9]) in the development and pathogenesis of arthritis. METHODS: We generated TIARP-deficient (TIARP(-/-) ) mice and investigated several organs in aged mice. Peritoneal macrophages were collected and cultured with lipopolysaccharide (LPS) and TNFα, and then the production of cytokines and subsequent NF-κB signal transduction were analyzed. We also examined the susceptibility of young TIARP(-/-)mice to collagen-induced arthritis (CIA). Draining lymph nodes and splenocytes were isolated and cultured, and serum levels of anti-type II collagen (anti-CII) antibodies, interleukin-6 (IL-6), and TNFα on day 60 were measured. We further investigated the effects of anti-IL-6 receptor monoclonal antibody (mAb) on the development of arthritis in TIARP(-/-)mice. IL-6/STAT-3 signaling was also analyzed using TIARP(-/-) macrophages. RESULTS:TIARP(-/-)mice developed spontaneous enthesitis and synovitis, had high serum levels of IL-6, had increased CD11b+ cell counts in the spleen, and showed enhanced LPS- and TNFα-induced IL-6 expression in macrophages. Sustained degradation of IκBα with dysregulated apoptosis was also noted in TIARP(-/-) macrophages. CIA was clearly exacerbated in TIARP(-/-)mice, accompanied by marked neutrophil and macrophage infiltration in joints. The levels of anti-CII antibodies in serum were unchanged, whereas autoreactive Th1 cell and Th17 cell responses were higher in TIARP(-/-)mice. Treatment with anti-IL-6 receptor mAb prevented the development of CIA in TIARP(-/-)mice, and TIARP(-/-) macrophages showed increased IL-6-induced STAT-3 phosphorylation. CONCLUSION: These findings suggest that TIARP acts as a negative regulator of arthritis by suppressing IL-6 production, its signaling and TNFα-induced NF-κB signaling, resulting in enhanced apoptosis in macrophages.
Authors: H Ebe; I Matsumoto; H Kawaguchi; I Kurata; Y Tanaka; A Inoue; Y Kondo; H Tsuboi; T Sumida Journal: Clin Exp Immunol Date: 2017-11-16 Impact factor: 4.330
Authors: C Takai; I Matsumoto; A Inoue; N Umeda; Y Tanaka; Y Kurashima; Y Wada; I Narita; T Sumida Journal: Clin Exp Immunol Date: 2015-06 Impact factor: 4.330
Authors: René H M Raeven; Jolanda Brummelman; Jeroen L A Pennings; Larissa van der Maas; Wichard Tilstra; Kina Helm; Elly van Riet; Wim Jiskoot; Cécile A C M van Els; Wanda G H Han; Gideon F A Kersten; Bernard Metz Journal: Sci Rep Date: 2016-12-01 Impact factor: 4.379
Authors: A Pascual; M Pauletto; A Trocino; M Birolo; M Dacasto; M Giantin; F Bordignon; C Ballarin; M Bortoletti; G Pillan; G Xiccato Journal: J Anim Sci Biotechnol Date: 2022-08-17
Authors: Sung Won Lee; Jee Hyun Rho; Sang Yeob Lee; Won Tae Chung; Yoo Jin Oh; Jung Ha Kim; Seung Hee Yoo; Woo Young Kwon; Ju Yong Bae; Su Young Seo; Hokeun Sun; Hye Young Kim; Young Hyun Yoo Journal: Bone Res Date: 2018-07-06 Impact factor: 13.567
Authors: A Pascual; M Pauletto; M Giantin; G Radaelli; C Ballarin; M Birolo; C Zomeño; M Dacasto; M Bortoletti; M Vascellari; G Xiccato; A Trocino Journal: J Anim Sci Biotechnol Date: 2020-05-01